The Institutional Biosafety Committee (IBC) is a campus committee empowered by federal regulations to oversee research activities involving recombinant DNA, transgenic animals, human body fluids (including blood or blood products, nasal secretions, vaginal or penile secretions, feces), human tissue or cells in culture, human pathogens, potential pathogen sources or other potentially infectious materials (OPIMs). The IBC is responsible for the review and monitoring of research involving these materials in order to ensure that every precaution is taken so the researchers and the general public remain safe while biological and biomedical research is being conducted.
Protocol approval must be acquired prior to the start of a research project.
- If you question whether or not your [ subject/material] research needs compliance approval, please contact Kris Schwab, Committee Chairperson.
- If your research may require approval from more than one compliance committee, you must submit separate protocols to each committee via IRBNet.